FDA Inspection
Genentech, Inc.Genentech, Inc. – FDA Inspection, Oct 23, 2012
Record Details
This FDA Inspection record concerns Genentech, Inc., with an inspection on October 23, 2012, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Genentech, Inc.
- Inspection Date
- October 23, 2012
- Product Type
- Drugs
View Company Profile
ID · 5cfadfae-1090-434a-bfe2-c4406514acc2
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 810079
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
1- 21 CFR 312.50Ensuring compliance with plan and protocol
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Genentech, Inc.
34| Date | Classification | Office | Project area |
|---|---|---|---|
| August 4, 2026 | Not classified | San Francisco District Office | |
| May 15, 2026 | Not classified | San Francisco District Office | |
| April 7, 2026 | Not classified | San Francisco District Office | |
| April 21, 2025 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| May 2, 2024 | VAI | Center for Drug Evaluation and Research | Postmarket Surv. and Epidemiology |
Other documents for Genentech, Inc.
- FDA Inspection 1332732 - 2026-08-04
- FDA Inspection 1322404 - 2026-05-15
- FDA Inspection 1314654 - 2026-04-07
- FDA Inspection 1263573 - 2025-04-21
- FDA Inspection 1236964 - 2024-05-02
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.